MASTER SUM LTD v. ASIALAND LTD AND OTHERS

MASTER SUM LTD v. ASIALAND LTD AND OTHERS

Court allowed final judgment on parts of the claims: HK$1,500,000 and HK$400,000 against Advance Pharmaceutical Company Limited and HK$137,750 against Loyal Advance Limited, because plaintiffs' evidence on those heads was prima facie sustainable and defendants' factual assertions were inadequate to defeat them at an Order 14 stage; the remainder of the plaintiffs' claims were left for trial with unconditional leave to defend; costs reserved and parties ordered to file submissions on costs.

Citation
MASTER SUM LTD v. ASIALAND LTD AND OTHERS
Parties
1st Plaintiff: Lam Yiu Cho; 2nd Plaintiff: New Rainbow Overseas Incorporated; Plaintiff (hca 2339/2007): Master Sum Limited; 1st Defendant: Asialand Limited; 2nd Defendant: Cheng Chi Heng; 3rd Defendant: Advance Pharmaceutical Company Limited; 4th Defendant: Loyal Advance Limited
Court
Court of First Instance
Jurisdiction
Hong Kong
Judgment Date
16 December 2008
Case Number
HCA2339/2007
Procedural Posture
Civil (contract) / Judgment on Summonses Arising From Order 14 Interlocutory Applications
Outcome
Final judgment entered in part for the plaintiffs; remainder of claims adjourned with unconditional leave to defend; costs reserved
Legal Topics
Implied Terms, Dividends and Accounts, Issue Estoppel, Consideration, Stakeholder/agency, Costs
Source Language
EN

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 8 Party arguments 2 Amounts and remedies 4
Sign in to unlock

Parties

Lam Yiu Cho

1st Plaintiff

New Rainbow Overseas Incorporated

2nd Plaintiff

Master Sum Limited

Plaintiff (hca 2339/2007)

Asialand Limited

1st Defendant

Cheng Chi Heng

2nd Defendant

Advance Pharmaceutical Company Limited

3rd Defendant

Loyal Advance Limited

4th Defendant

Procedural Posture

Civil (contract) / Judgment on Summonses Arising From Order 14 Interlocutory Applications

  1. 1 Whether an implied term should be read into the share sale agreement requiring Asialand to assist in obtaining IRD confirmation
  2. 2 Whether the plaintiffs' claim against Asialand and guarantor Cheng was premature or should have been brought against the stakeholder
  3. 3 Whether Asialand breached clause 11 by failing to cause AP to issue accounts or declare dividends

Ratio Decidendi

Court allowed final judgment on parts of the claims: HK$1,500,000 and HK$400,000 against Advance Pharmaceutical Company Limited and HK$137,750 against Loyal Advance Limited, because plaintiffs' evidence on those heads was prima facie sustainable and defendants' factual assertions were inadequate to defeat them at an Order 14 stage; the remainder of the plaintiffs' claims were left for trial with unconditional leave to defend; costs reserved and parties ordered to file submissions on costs.

Court Disposition

Final judgment entered in part for the plaintiffs; remainder of claims adjourned with unconditional leave to defend; costs reserved

Orders

  • Final judgment for HK$1,500,000 against Advance Pharmaceutical Company Limited
  • Final judgment for HK$400,000 against Advance Pharmaceutical Company Limited